Beyond Cancer Drugs: Why India Needs Strict Regulation on Wholesale Pharma Margins

Treatment of cancer is usually compared to a war against the disease. For thousands of Indian families, the struggle becomes a second one against the cost of medicines that may cause a significant financial burden for households even if the treatment is carried out at a governmental hospital or with the help of health insurance. Public debate on the cost of cancer medicines has raised another essential issue: should India control the margin of wholesalers? While the public interest usually focus

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.